Gout Cannot Be Diagnosed Based on Serum Uric Acid Level Alone
The diagnosis of gout should NOT be made on the presence of hyperuricemia alone 1. There is no specific serum uric acid threshold that diagnoses gout—the diagnosis requires either crystal identification or a combination of clinical features with hyperuricemia as a supportive finding.
The Three-Step Diagnostic Approach
Step 1: Crystal Identification (Gold Standard)
- Demonstration of monosodium urate (MSU) crystals in synovial fluid or tophus aspirates is the definitive diagnostic method 1
- This should be attempted in every patient with suspected gout
- Synovial fluid aspiration is strongly recommended for any undiagnosed inflammatory arthritis 1
Step 2: Clinical Diagnosis (When Crystal Identification Not Feasible)
When synovial fluid analysis cannot be performed, gout diagnosis is supported by these clinical features 1:
- Monoarticular involvement of foot (especially first MTP joint) or ankle
- Previous similar acute arthritis episodes
- Rapid onset of severe pain/swelling (worst within <24 hours)
- Erythema
- Male gender
- Associated cardiovascular diseases
- Hyperuricemia (as a supportive feature, not diagnostic alone)
Step 3: Imaging
When clinical diagnosis is uncertain and crystals cannot be identified 1:
- Ultrasound: Detects tophi and "double contour sign" (highly specific for urate deposits)
- Dual-energy CT: Sensitivity 71-97%, specificity 85-95% 1
- Plain radiographs have limited value for acute flares
Critical Pitfall: Why Hyperuricemia Alone Is Insufficient
The evidence is unequivocal on this point:
- Only 22% of asymptomatic patients with SUA >9 mg/dL develop gout over 5 years 1
- Specificity of hyperuricemia for gout diagnosis is only 53-61% 1
- Approximately 10% of people with confirmed gout have normal SUA levels during acute attacks 1, 2
This means hyperuricemia is a risk factor, not a diagnostic criterion. Conversely, normal SUA during an acute flare does not exclude gout—this "normouricemic gout" presents a diagnostic challenge and often shows more pronounced inflammation 2.
Real-World Diagnostic Uncertainty
A 2024 study found that 43% of general practitioners diagnosed gout without testing SUA at all 3, leading to substantial diagnostic uncertainty. When GPs made diagnoses without punctually-timed SUA testing, the diagnoses were often questionable or incorrect according to validated diagnostic rules 3.
Treatment Threshold vs. Diagnostic Threshold
While there is no diagnostic SUA threshold, treatment targets are clear:
- Target SUA <6 mg/dL (360 μmol/L) for urate-lowering therapy 4, 5
- For tophaceous gout: target <5 mg/dL (300 μmol/L) 4
These treatment thresholds should not be confused with diagnostic criteria—they apply only after gout has been properly diagnosed through crystal identification or validated clinical algorithms.